Used in research settings as a selective antagonist for dopamine D3 receptors, aiding in the study of neurological pathways related to addiction, schizophrenia, and Parkinson’s disease. Shows potential in behavioral pharmacology studies due to its ability to differentiate D3 from D2 receptor activity. Also employed in radiolabeled form for receptor binding assays and neuroimaging experiments.